Within this study we analysed the distribution of angiogenic markers: sFlt1, PIGF, VEGF, VEGF-C and VEGF-D and reveal the differences of their expression in the sera of breast cancer patients with and without circulating tumour cells. Here, VEGFC is linked to neoplasm.